In the results of immune infiltration (Figures 4, 5), we observed that expression of LAPTM4B is positively correlated with CD8 T cells, and is lower in high-grade renal cancer than in early-stage renal cancer, possibly explaining the poor response to treatment in advanced renal cancer. The gene discussed is LAPTM4B; the disease is renal carcinoma.